Leiden University Medical Center (LUMC) will start this year with the construction of the largest non-profit stem cell and gene therapy facility in the Netherlands, and one of the largest facilities in Europe.
The Leiden University Medical Center (LUMC) has exclusively licensed its recently developed gene therapy program to treat Inherited Retinal Dystrophy to French therapy developer HORAMA for further clinical development.
Start project: 2019
Involved institutes: LUMC, Inserm
Stage: Preclinical
Status: Ongoing
Start project: 2018
Involved institutes: LUMC
Stage: Preclinical
Status: Completed
Start project: 2018
Involved institutes: LUMC
Stage: Preclinical
Status: Completed
